AU2002342770A1 - Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised - Google Patents

Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised

Info

Publication number
AU2002342770A1
AU2002342770A1 AU2002342770A AU2002342770A AU2002342770A1 AU 2002342770 A1 AU2002342770 A1 AU 2002342770A1 AU 2002342770 A AU2002342770 A AU 2002342770A AU 2002342770 A AU2002342770 A AU 2002342770A AU 2002342770 A1 AU2002342770 A1 AU 2002342770A1
Authority
AU
Australia
Prior art keywords
sterilised
liposomes
sterile
filtered
heat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002342770A
Inventor
Jorg Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU2002342770A1 publication Critical patent/AU2002342770A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002342770A 2001-09-28 2002-09-27 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised Abandoned AU2002342770A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10148067A DE10148067A1 (en) 2001-09-28 2001-09-28 Heat sterilizable alkyl phosphocholine liposomes
DE10148067.9 2001-09-28
PCT/EP2002/010882 WO2003028736A2 (en) 2001-09-28 2002-09-27 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised

Publications (1)

Publication Number Publication Date
AU2002342770A1 true AU2002342770A1 (en) 2003-04-14

Family

ID=7700759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342770A Abandoned AU2002342770A1 (en) 2001-09-28 2002-09-27 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised

Country Status (3)

Country Link
AU (1) AU2002342770A1 (en)
DE (1) DE10148067A1 (en)
WO (1) WO2003028736A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60325459D1 (en) 2002-02-19 2009-02-05 Resolution Chemicals Ltd SOLVENT BASED STERILIZATION OF STEROIDS
WO2006024675A1 (en) * 2004-09-03 2006-03-09 Forschungszentrum Karlsruhe Gmbh Use of alkylphospholipids for the treatment of solid tumours
US8828972B2 (en) 2004-10-19 2014-09-09 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Formulations containing alkylphosphocholines using novel negative charge carriers
AU2006328479B2 (en) * 2005-12-19 2012-03-08 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
DE102009007853A1 (en) * 2009-02-06 2010-08-12 LMU Ludwig-Maximilians-Universität München Intraocular lenses treated with alkylphosphocholines for pharmacological after-stage prophylaxis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088046B1 (en) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipids in the aqueous phase
DE4132345A1 (en) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Medicament compsns. for intravenous admin. of lytic agents - used for treatment of tumours, auto-immune disorders, multiple sclerosis, etc.
DE4408011C1 (en) * 1994-03-10 1995-11-02 Max Delbrueck Centrum Liposomes for tumour therapy
DE10015814A1 (en) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Medicines to stimulate leukopoiesis, treat tumors and protozoan diseases and process for its manufacture

Also Published As

Publication number Publication date
DE10148067A1 (en) 2003-04-17
WO2003028736A3 (en) 2003-12-04
WO2003028736A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
HK1068812A1 (en) Drug preparations
GB0018828D0 (en) Alkyl Amino Acid Derivatives useful as pharmaceutical agents
AU2001259389A1 (en) Math coprocessor
AU2002324990A1 (en) Three-dimensional electrophoretic displays
AUPR392301A0 (en) Protein phosphatase inhibitors
IL154705A0 (en) Polyarylcarboxamides useful as lipid lowering agents
AU2002347910A1 (en) Methods and compositions for targeting proteins across the blood brain barrier
HK1073310A1 (en) Biphenylcarboxamides useful as lipid lowering agents
AU2001259059A1 (en) Beta-glucans encapsulated in liposomes
AU2002214131A1 (en) Improved 3d display
AU2001283530A1 (en) Dual-domain lateral shearing interferometer
AU2002342770A1 (en) Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised
AU2001269888A1 (en) Protein phosphatases
AU2002240942A1 (en) Improved delivery of benefit agents
AU2001283012A1 (en) Protein phosphatases
AU2002361850A1 (en) Medicinal aerosol formulations comprising ion pair complexes
AU2001292301A1 (en) Novel drugs for liver diseases
AU2001292870A1 (en) Protein phosphatases
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001284827A1 (en) Virtual showcases
AU2001292001A1 (en) Pharmaceutical oxan preparation
AU2001261039A1 (en) Protein phosphatases
AU2002353208A1 (en) Metalloprotease proteins
AU2002214332A1 (en) Ophthalmological preparations
AU2002327135A1 (en) Liposome preparations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase